Atai Life Sciences founder on using psychedelics to treat mental illness

Atai Life Sciences, a biotech company that uses psychedelics to treat mental illness, is going public on the Nasdaq Friday. Christian Angermayer, Atai Life Sciences founder, joined "Squawk Box" on Friday to discuss the company's mission and public debut.

[nottheone]

I'm so excited for the future of the psychedelics market, but this interview was not it. they need to hire a PR/CMO who is strong on camera, I don't think the founder/ceo is very compelling for TV

[emar]

Excited for this


everyone after 🧟‍♀️

[jl.c.]

That CEO is highly anxious.
Does not seem to work.

[JBrooks]

Suggesting the interviewer did them years back probably isn't the best move for a first TV appearance

[jackpeterson]

Does anyone know of any platforms I can trade $ATAI or MindMed in the UK?

[steveo]

I wish he would stick to the scientific facts of the potential of psychedelics to cure depressions rather than playing to outmoded stereotypes such as people "tripping with their therapists." I feel much less enlightened about what ATAI is doing after watching this. Not a great interview IMO.